Judge overturns FDA’s lab developed test regulation, siding with industry
- On Monday, a Texas federal court struck down the FDA's new rule regulating laboratory developed tests as medical devices.
- The FDA's attempt to regulate lab-developed tests stemmed from the absence of amended legislation clarifying its authority.
- Judge Sean Jordan vacated the FDA's final rule in its entirety and remanded the matter to HHS Secretary Robert F. Kennedy Jr.
- ACLA President Susan Van Meter stated this victory protects patient access, while AMP President Jane Gibson noted billions in healthcare costs would be avoided.
- The court's decision means the FDA's rule and its compliance deadlines are no longer in effect, pending potential congressional action.
9 Articles
9 Articles
In Landmark Ruling, Eastern District of Texas Strikes Down FDA’s Final Rule Regulating Laboratory Developed Tests
Link URL: https://natlawreview.com/article/landmark-ruling-eastern-district-texas-strikes-down-fdas-final-rule-regulating Comments URL: https://tildes.net/~health/1n41/eastern_district_of_texas_strikes_down_food_and_drug_administrations_final_rule_regulating Votes: 7 Comments: 2
America's Blood Centers Responds to Court Striking Down FDA Overreach on In Vitro Diagnostics Unlawful
Decision is a victory for patient care and laboratory innovation Washington, DC – America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, today released this statement following the U.S. District Court for the Eastern District of Texas’ determination that the Food and Drug Administration’s (FDA) 2024 final rule subjecting in vitro diagnostic produ…
Coverage Details
Bias Distribution
- 80% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage